Dopamine

cannabinoid receptor 1 ; Homo sapiens







26 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35470551 Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study. 2022 May 6
2 30882962 Modulatory effects of cannabinoids on brain neurotransmission. 2019 Aug 1
3 29063964 Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology. 2018 Feb 2
4 27639448 Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks. 2017 May 1
5 26123153 Roles for the endocannabinoid system in ethanol-motivated behavior. 2016 Feb 4 2
6 25510937 Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction. 2015 May 1
7 25859226 Role of the endogenous cannabinoid system in nicotine addiction: novel insights. 2015 1
8 24334069 Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta. 2014 Apr 1
9 24495779 Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. 2014 Jul 3 1
10 25014618 Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population. 2014 Oct 3
11 25090972 Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway. 2014 Nov 2
12 22391102 The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. 2013 Mar 1
13 23422373 CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia. 2013 Apr 1
14 22265889 Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output. 2012 Jul 2 1
15 22306525 Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism. 2012 Jun 2
16 22421165 The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015. 2012 Apr 10 1
17 22692568 Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems. 2012 Oct 4
18 19367507 Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. 2009 Apr 2
19 18213623 Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. 2008 Dec 5 1
20 16762556 Protective activation of the endocannabinoid system during ischemia in dopamine neurons. 2006 Oct 1
21 15878779 Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. 2005 Jun 2
22 14993102 Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. 2004 Apr 1
23 15125311 [Role of endogenous cannabinoids in cerebral reward mechanisms]. 2004 Mar 1
24 14623357 The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. 2003 Nov 7 1
25 11803524 Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. 2001 Dec 8 1
26 11138722 Role of cannabinoid receptor in the brain as it relates to drug reward. 2000 Nov 1